Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger rna expression

Neuroscience

Volumn 92, Issue 3, 1999, Pages 945-966

  Mavridis, M ^a   Besson, M J ^a  

^a CNRS   (France)

Author keywords

Dopamine; Globus pallidus; Glutamate decarboxylase; Neostriatum; Opioid peptides; Regulation

Indexed keywords

DOPAMINE; DYNORPHIN; ENKEPHALIN; GLUTAMATE DECARBOXYLASE; HALOPERIDOL; MESSENGER RNA; NALOXONE; OPIATE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DYNORPHINS; ENKEPHALINS; GLOBUS PALLIDUS; GLUTAMATE DECARBOXYLASE; HALOPERIDOL; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEOSTRIATUM; NEURONS; OPIOID PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 0033024288     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00043-3     Document Type: Article

References (107)

1. Agid Y. Parkinson's disease: pathophysiology. Lancet. 337:1991;1321-1324.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Bals-Kubik R., Herz A., Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated. Psychopharmacology. 98:1989;203-206.
4. Baronti F., Conant K.E., Giuffra M., Davis T.L., Brughitta G., Iadarola M.J., Berrettini W.H., Chase T.N., Mouradian M.M. Opioid peptides in Parkinson's disease: effects of dopamine repletion. Brain Res. 560:1991;92-96.
5. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
6. Bergstrom D.A., Walters J.R. Dopamine attenuates the effects of GABA on single unit activity in the globus pallidus. Brain Res. 310:1984;23-33.
7. Bergstrom D.A., Bromley S.D., Walters J.R. Apomorphine increases the activity of rat globus pallidus neurons. Brain Res. 238:1982;266-271.
8. Brady L.S., Herkenham M., Long J.B., Rothman R.B. Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 477:1989;382-386.
9. 1 receptor distribution. Devl Brain Res. 58:1991;111-122.
10. 2 receptors in the regulation of glutamate decarboxylase messenger RNA in the striatum of the rat. Eur. J. Neurosci. 4:1992;438-447.
11. Civelli O., Bunzow J.R., Grandy D.K., Zhou Q.-Y., Van Tol H.H.M. Molecular biology of the dopamine receptors. Eur. J. Pharmac. molec. Pharmac. 207:1991;277-286.
12. Civelli O., Douglas J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. natn. Acad. Sci. U.S.A. 82:1985;4291-4295.
13. Crossman A.R., Mitchell I.J., Sambrook M.A., Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. Brain. 111:1988;1211-1233.
14. Dacko S., Schneider J.S. Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms. Neurosci. Lett. 127:1991;49-52.
15. Delay-Goyet P., Zajac J.-M., Roques B.P. Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase and on μ- and δ-opioid binding sites: comparison with chronic morphine and chronic kelatorphan. Neurosci. Lett. 103:1989;197-202.
16. Delfs J.M., Anegawa N.J., Chesselet M.-F. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience. 66:1995;67-80.
17. Delfs J.M., Ciaramitaro V.M., Parry T.J., Chesselet M.-F. Subthalamic nucleus lesions: widespread effects on changes induced by nigrostriatal dopamine depletion in rats. J. Neurosci. 15:1995;6562-6575.
18. Delfs J.M., Ellison G.D., Mercugliano M., Chesselet M.-F. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Expl Neurol. 133:1995;175-188.
19. Delfs J.M., Yu L., Ellison G.D., Reisine T., Chesselet M.-F. Regulation of μ-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration. J. Neurochem. 63:1994;777-780.
20. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis study. J. Pharmac. exp. Ther. 266:1993;1236-1246.
21. Dewar D., Jenner P., Marsden C.D. Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus. Neuroscience. 15:1985;41-46.
22. 3H-5HT from slices of rat globus pallidus. Biochem. Pharmac. 36:1987;1738-1741.
23. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmac. exp. Ther. 244:1988;1067-1080.
24. 2 agonists. Eur. J. Pharmac. 200:1991;171-173.
25. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res. 581:1992;261-268.
26. Filion M., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;142-151.
27. Frey J.M., Huffman R.D. Effects of enkephalin and morphine on rat globus pallidus neurons. Brain Res. Bull. 14:1985;251-259.
28. Gerfen C.R., Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
29. Gerfen C.R., McGinty J.F., Young III W.S. Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
30. 2 dopamine receptor stimulation in the dorsal caudate putamen. Neuroscience. 19:1986;1109-1117.
31. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signature. Molec. Pharmac. 36:1989;265-272.
32. Goto S., Hirano A., Matsumoto S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology. 40:1990;1051-1056.
33. Grace A.A., Bunney B.S. Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmac. 59:1979;211-218.
34. Herkenham M., Pert C.B. Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J. Neurosci. 2:1982;1129-1149.
35. Hommer D.W., Pert A. The actions of opiates in the rat substantia nigra: an electrophysiological analysis. Peptides. 4:1983;603-608.
36. Hooks M.S., Jones D.N.C., Justice J.B. Jr., Holtzman S.G. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmac. Biochem. Behav. 42:1992;765-770.
37. Howells R.D., Kilpatrick D.L., Bhatt R., Monahan J.J., Poonian M., Udenfriend S. Molecular cloning and sequence determination of rat preproenkephalin cDNA: sensitive probe for studying transcriptional changes in rat tissues. Proc. natn. Acad. Sci. U.S.A. 81:1984;7651-7655.
38. Itoh M. Effect of haloperidol on glutamate decarboxylase activity in discrete brain areas of the rat. Psychopharmacology. 79:1983;169-172.
39. Javoy-Agid F., Hirsch E.C., Dumas S., Duyckaert C., Mallet J., Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience. 38:1990;245-253.
40. Jiang Z.G., North R.A. Pre- and postsynaptic inhibition by opioids in rat striatum. J. Neurosci. 12:1992;356-361.
41. Jiang H.-K., McGinty J.F., Hong J.S. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507:1990;57-64.
42. Johnson P.I., Napier T.C. Morphine modulation of GABA- and glutamate-induced changes of ventral pallidal neuronal activity. Neuroscience. 77:1997;187-197.
43. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
44. Kincaid A.E., Albin R.L., Newman S.W., Penney J.B., Young A.B. 6-hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA expression in rat globus pallidus projection neurons. Neuroscience. 51:1992;705-718.
45. Kita H., Kitai S.T. Intracellular study of the rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res. 564:1991;296-305.
46. Levy R., Hazrati L.-N., Herrero M.-T., Vila M., Hassani O.-K., Mouroux M., Ruberg M., Asensi H., Agid Y., Féger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
47. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.-F., Broussolle E., Perret J.E., Benabid A.-L. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
48. Lindvall O., Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172:1979;169-173.
49. Maneuf Y.P., Mitchell I.J., Crossman A.R., Brotchie J.M. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Expl Neurol. 125:1994;65-71.
50. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. comp. Neurol. 350:1994;412-438.
51. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
52. Mao C.C., Cheney D.L., Marco E., Revuelta A., Costa E. Turnover times of gamma-aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol. Brain Res. 132:1977;375-379.
53. 2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Res. 632:1993;308-313.
54. Martin G., Nie Z., Siggins G.R. μ-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17:1997;11-22.
55. Matsumoto R.R., Brinsfield K.H., Patrick R.L., Walker J.M. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. J. Pharmac. exp. Ther. 246:1988;196-203.
56. ®) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression. Neuroscience. 66:1995;37-53.
57. Mercugliano M., Saller C.F., Salama A.I., U'Prichard D.C., Chesselet M.-F. Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. Neuropsychopharmacology. 6:1992;179-187.
58. r 67,000) in the basal ganglia of the rat. J. comp. Neurol. 318:1992;245-254.
59. 2 antagonists. Neuroscience. 25:1988;525-532.
60. Morris B.J., Höllt V., Herz A. Opioid gene expression in rat striatum is modulated via opioid receptors: evidence from localized receptor inactivation. Neurosci. Lett. 89:1988;80-84.
61. Morris B.J., Millan M.J., Herz A. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. J. Pharmac. exp. Ther. 247:1988;729-736.
62. Mucha R.F., Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology. 86:1985;274-280.
63. Mugnaini E. and Oertel W. H. (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In Handbook of Chemical Neuroanatomy (eds Björklund A. and Hökfelt T.), Vol. 4, pp. 436-608. Elsevier, Amsterdam.
64. Napier T.C., Simson P.E., Givens B.S. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J. Pharmac. exp. Ther. 258:1991;249-262.
65. Pan H.S., Walters J.R. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse. 2:1988;650-656.
66. Pan H.S., Penney J.B., Young A.B. γ-Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J. Neurochem. 45:1985;1396-1404.
67. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20:1995;128-154.
68. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, San Diego.
69. Pentney R.J.W., Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience. 45:1991;95-102.
70. Petit F., Hamon M., Fournie-Zaluski M.-C., Roques B.P., Glowinski J. Further evidence for a role of δ-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Eur. J. Pharmac. 126:1986;1-9.
71. Quirion R., Gaudreau P., Martel J.-C., St-Pierre S., Zamir N. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra. Brain Res. 331:1985;358-362.
72. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ- and μ-opioid receptors. Molec. Pharmac. 45:1994;330-334.
73. Reiner A., Anderson K.D. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15:1990;251-265.
74. Rétaux S., Trovero F., Besson M.J. Role of dopamine in the plasticity of glutamic acid decarboxylase messenger RNA in the rat frontal cortex and the nucleus accumbens. Eur. J. Neurosci. 6:1994;1782-1791.
75. Robledo P., Féger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518:1990;47-54.
76. Romualdi P., Lesa G., Ferri S. Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Res. 563:1991;132-136.
77. Ryan L.J., Clark K.B. Alteration of neuronal responses in the subthalamic nucleus following globus pallidus and neostriatal lesions in rats. Brain Res. Bull. 29:1992;319-327.
78. Scheel-Krüger J. On the role of GABA for striatal functions. Interaction between GABA and enkephalin in the pallidal systems. Neuropharmacology. 23:1984;867-868.
79. Scheel-Krüger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta neurol. scand. 107(Suppl.):1986;1-54.
80. Schoffelmeer A.N.M., Rice K.C., Jacobson A.E., Van Gelderen J.G., Hogenboom F., Heijna M.H., Mulder A.H. μ-, δ- and κ-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur. J. Pharmac. 154:1988;169-178.
81. Seeman P., Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem. Int. 10:1987;1-25.
82. Shippenberg T.S., Bals-Kubik R., Herz A. Motivational properties of opioids: evidence that an activation of δ-receptors mediates reinforcement processes. Brain Res. 436:1987;234-239.
83. Siegel S. (1956) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.
84. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13:1990;259-265.
85. Smith J.A.M., Leslie F.M., Broide R.S., Loughlin S.E. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra. Neuroscience. 55:1993;935-951.
86. 3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Molec. Pharmac. 42:1992;575-583.
87. Smith Y., Lavoie B., Dumas J., Parent A. Evidence for a distinct nigropallidal dopaminergic projection in the squirrel monkey. Brain Res. 482:1989;381-386.
88. Soghomonian J.-J., Chesselet M.-F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse. 11:1992;124-133.
89. Soghomonian J.-J., Gonzales C., Chesselet M.-F. Messenger RNAs encoding glutamate-decarboxylase are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res. 576:1992;68-79.
90. Soghomonian J.-J., Pedneault S., Audet G., Parent A. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J. Neurosci. 14:1994;6256-6265.
91. 3H-dopamine release in anesthetized, awake restrained and freely moving rats. Brain Res. Bull. 16:1986;161-166.
92. Steiner H., Gerfen C.R. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. comp. Neurol. 353:1995;200-212.
93. Tang F., Costa E., Schwartz J.P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. natn. Acad. Sci. U.S.A. 80:1983;3841-3844.
94. Tao P.-L., Lee H.-Y., Chang L.-R., Loh H.H. Decrease in μ-opioid receptor binding capacity in rat brain after chronic PL017 treatment. Brain Res. 526:1990;270-275.
95. 5-enkephalin in the human brain. Brain Res. 280:1983;379-382.
96. Tempel A., Gardner E.L., Zukin R.S. Visualization of opiate receptor upregulation by light microscopy autoradiography. Proc. natn. Acad. Sci. U.S.A. 81:1984;3893-3897.
97. Tempel A., Kessler J.A., Zukin R.S. Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions. J. Neurosci. 10:1990;741-747.
98. Trovero F., Hervé D., Desban M., Glowinski J., Tassin J.-P. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat. Neuroscience. 39:1990;313-321.
99. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
100. Uhl G.R., Childers S., Pasternak G. An opiate-receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
101. Uhl G.R., Ryan J.P., Schwartz J.P. Morphine alters preproenkephalin gene expression. Brain Res. 459:1988;391-397.
102. Waksman G., Hamel E., Delay-Goyet P., Roques B.P. Neutral endopeptidase-24.11, μ and δ opioid receptors after selective brain lesions: an autoradiographic study. Brain Res. 436:1987;205-216.
103. Walker J.M., Thompson L.A., Frascella J., Friederich M.W. Opposite effects of μ and κ opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur. J. Pharmac. 134:1987;53-59.
104. Westerink B.H.C., de Vries J.B. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci. Lett. 99:1989;197-202.
105. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6:1996;751-758.
106. Wyborski R.J., Bond R.W., Gottlieb D.I. Characterization of a cDNA coding for rat glutamic acid decarboxylase. Molec. Brain Res. 8:1990;193-198.
107. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9827-9831.